EUVIMEDEUVIMED entdecken
Crossref

The Correlation Among PD ‐ L1 Expression and the Driver Genes Status in Malignant Pleural Effusion of Lung Adenocarcinoma

Rui Wang iD, Yang Ma, Ying Liu iD, Juan Wu, Xiao Guo, Yun Du

Cytopathology · 2026

DOI: 10.1111/cyt.70052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cytopathology, 2026. Verfasst von Rui Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cytology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China. Hauptthemen laut MEDLINE: B7-H1 Antigen, Pleural Effusion, Malignant, Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Medical Science Research Project of Hebei, Medical Technology Tracking Project of Hebei.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The objective of this study was to investigate the protein expression of PD‐L1 in the pleural fluid of lung adenocarcinoma patients with malignant pleural effusion. Additionally, we aimed to analyse the association between PD‐L1 expression and the mutational status of ten driver genes: EGFR, ALK, ROS1, BRAF, KRAS, NRAS, HER2, RET, PIK3CA, and MET.

Methods

A total of 161 cytological specimens were collected from patients that had been diagnosed with lung adenocarcinoma at the Fourth Hospital of Hebei Medical University between January 2021 and September 2024. The cytologic samples were tested for tumour PD‐L1 expression using a VENTANA PD‐L1 (SP263) assay. EGFR, ALK, ROS1, BRAF, KRAS, NRAS, HER2, RET, PIK3CA, and MET mutations in the fresh cytological samples were detected using an amplification refractory mutation system and an ABI 7500 RT–qPCR system.

Results

Among 161 pleural fluid cytological specimens, 24.2% (39/161) presented a PD‐L1 tumour proportion score (TPS) of ≥ 50%, whereas 39.1% (63/161) presented a TPS ranging from 1% to 49%. Additionally, 36.7% (59/161) demonstrated a TPS of < 1%. The mutation status analysis of 160 pleural fluid cytological specimens revealed EGFR mutations in 75 cases (46.9%), no mutations in 35 cases (21.9%), KRAS mutations in 20 cases (12.5%), ALK mutations in 9 cases, BRAF mutations in 7 cases, MET mutations in 3 cases, ROS1 mutations in another set of 3 cases, and other types of mutations identified in an additional 8 cases. The expression level of PD‐L1 in pleural fluid cytological samples from patients with EGFR mutations was not significantly different from that in those from patients with no mutations ( p = 0.473). In contrast, the expression levels of PD‐L1 in patients with KRAS, ALK, and BRAF mutations were significantly different from those in patients with no mutations ( p = 0.045; p = 0.007; p = 0.01).

Conclusion

Our findings suggest that PD‐L1 immunohistochemistry is effective for evaluating pleural fluid cytological specimens and that PD‐L1 expression is significantly higher in lung adenocarcinoma patients with malignant pleural effusions associated with the KRAS, ALK and BRAF mutations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7-H1 AntigenPleural Effusion, MalignantAdenocarcinoma of LungLung NeoplasmsHumansFemaleMaleAgedMiddle AgedMutationAdultAged, 80 and overBiomarkers, Tumor

Stichwörter der Autor:innen

PD‐L1driver genesimmunocytochemical staininglung adenocarcinomamalignant pleural effusion

Substanzen

B7-H1 AntigenCD274 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Cytology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China.

ORCID-Profile: Rui Wang, Ying Liu

Förderung

  • Medical Science Research Project of Hebei
  • Medical Technology Tracking Project of Hebei

Zitieren

APA

Wang, R., Ma, Y., Liu, Y., Wu, J., Guo, X., & Du, Y. (2026). The Correlation Among PD ‐ L1 Expression and the Driver Genes Status in Malignant Pleural Effusion of Lung Adenocarcinoma. Cytopathology. https://doi.org/10.1111/cyt.70052

Vancouver

Wang R, Ma Y, Liu Y, Wu J, Guo X, Du Y. The Correlation Among PD ‐ L1 Expression and the Driver Genes Status in Malignant Pleural Effusion of Lung Adenocarcinoma. Cytopathology. 2026. doi:10.1111/cyt.70052

BibTeX
@article{Wang2026,
  author = {Wang, Rui and Ma, Yang and Liu, Ying and Wu, Juan and Guo, Xiao and Du, Yun},
  title = {The Correlation Among PD ‐ L1 Expression and the Driver Genes Status in Malignant Pleural Effusion of Lung Adenocarcinoma},
  journal = {Cytopathology},
  year = {2026},
  doi = {10.1111/cyt.70052}
}
Kostenlos starten →